Advertisement
Screener

CELCUITY INC. (CELC) Cash Flow Breakdown

CELCUITY INC. Cash Flow Breakdown

Cash flow breakdown shows where CELCUITY INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $153.28M went out.
  • Fiscal year ended 2025-12-31: from investing, $64.08M went out.
  • Fiscal year ended 2025-12-31: from financing, $360.55M came in.
  • Fiscal year ended 2025-12-31: change in cash, $143.19M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$153.28M-$64.08M$3.48M$357.07M*$143.19M
2024-12-31-$83.47M-$63.07M$770.00K$137.62M*-$8.15M
2023-12-31-$53.81M-$5.01M$388.52K$64.52M*$6.09M
2022-12-31-$36.01M-$144.03M$152.41K$120.17M*-$59.71M
2021-12-31-$20.31M-$81.40K$63.42K$92.98M*$72.65M
2020-12-31-$7.15M-$89.37K$0.00-$7.10M
2019-12-31-$6.00M$8.53M$174.96K$2.79M
2018-12-31-$6.08M$19.09M$0.00$13.25M
2017-12-31-$4.95M-$28.98M$0.00$30.71M*-$3.22M
2016-12-31-$2.89M-$40.90K$3.72M*$789.11K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$55.43M*-$330.59M*$1.68M*$421.20M*
2026-03-31-$55.06M$34.52M$206.00K-$20.51M
2025-12-31-$36.40M*$103.41M*$1.10M*$23.34M*
2025-09-30-$44.82M*-$257.61M*$2.36M*$327.96M*
2025-06-30-$36.21M*$65.86M*
2025-03-31-$35.85M$24.26M$5.55M*-$6.04M
2024-12-31-$27.77M*$37.56M*$104.00K*
2024-09-30-$20.56M*$1.90M*$331.00K*
2024-06-30-$18.07M*-$106.07M*$204.00K*$123.17M*
2024-03-31-$17.07M$3.54M$131.00K$13.95M*$552.00K
2023-12-31-$18.54M*-$41.22M*$102.96K*$64.55M*
2023-09-30-$12.75M*$6.25M*$44.00K*
2023-06-30-$9.66M*$8.09M*$113.64K*
2023-03-31-$12.87M$21.87M$127.92K$9.07M
2022-12-31-$9.48M*-$143.99M*$128.18K*$120.42M*
2022-09-30-$9.31M*-$12.10K*$7.28K*
2022-06-30-$11.29M*-$22.99K*$9.54K*
2022-03-31-$5.93M-$11.63K$7.41K-$5.99M
2021-12-31-$6.12M*-$9.94K*$21.46K*
2021-09-30-$4.05M*-$14.06K*$5.10K*$52.79M*
2021-06-30-$7.62M*-$26.97K*$14.35M*$6.70M*
2021-03-31-$2.52M-$30.43K$25.81M$23.30M
2020-12-31-$2.11M*-$13.88K*$0.00*-$2.06M*
2020-09-30-$1.65M*-$8.90K*$0.00*-$1.73M*
2020-06-30-$1.56M*-$20.98K*$0.00*-$1.42M*
2020-03-31-$1.83M-$45.60K$0.00-$1.88M
2019-12-31-$1.70M*$4.14M*$1.00*$2.47M*
2019-09-30-$1.48M*$2.83M*$0.00*$1.35M*
2019-06-30-$1.23M*$1.36M*$0.00*
2019-03-31-$1.59M$197.36K$174.96K-$1.22M
2018-12-31-$1.52M*$13.67M*$0.00*
2018-09-30-$1.77M*$2.37M*$0.00*
2018-06-30-$1.34M*$1.86M*$0.00*
2018-03-31-$1.45M$1.20M$0.00-$67.13K
2017-12-31-$1.11M*-$28.53M*-$29.66M*
2017-09-30-$1.63M*-$282.64K*$23.31M*
2017-06-30-$1.26M*-$155.47K*$7.43M*
2017-03-31-$947.14K-$10.38K-$957.52K
2016-12-31-$704.00K*-$10.13K*-$714.13K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERACYTE, INC. (VCYT)United States$3.904B41.21
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B